GlaxoSmithKline Pharmaceuticals has informed that the company will hold the 96th Annual General Meeting ('AGM') on Tuesday, 27th July, 2021, through Video Conferencing/ Other Audio Visual Means in accordance with the relevant circulars issued by Ministry of Corporate Affairs and Securities and Exchange Board of India; The Board of Directors has recommended a total dividend of Rs 30 per share for the financial year ended 31st March, 2021 on Equity Shares of Re 10 each, subject to the approval of shareholders at the forthcoming Annual General Meeting.
The above information is a part of company’s filings submitted to BSE.
